DKFZ has patented a novel annexin-formulation of enhanced receptor-mediated effects.
- Therapie und Wirkstoffe
DKFZ has patented a novel annexin-formulation of enhanced receptor-mediated effects.
Temperaturstabilisierung ist bei hochauflösenden Mikroskopen sehr wichtig. Die von DKFZ entwickelte Technologie ermöglicht mit Durchstrom von exakt...
Non-alcoholic fatty liver disease (NAFLD), comprising several liver diseases including NAFL and NASH, which is the most frequent liver disease...
Lung cancer is the leading cause of death among men and women in North America and attracts substantial pharmaceutical investment. However, in...
This invention provides a novel therapeutic strategy to prevent and treat different types of cancer. The microRNAs can target cancer associated...
This invention provides a method for an easy, economical and reliable post-synthetic modification of nucleic acids.
The Wnt signaling pathway plays an important role in the regulation of cell proliferation and differentiation. Aberrant activation of the Wnt...
DKFZ inventors identified the Wnt secretion protein Evi/Gpr177 as new target, which is strikingly upregulated during glioma tumorigenesis in a...
The invention relates to a peptide identical to human isocitrate dehydrogenase type 1 (IDH1) which can be used for diagnosis, vaccination and...
Solving the problem of poor pharmacokinetics by using the Fc domain of IgG being conjugated to endostatin, a component of all monoclonal antibodies...
Labeled oligonucleotides are used in research and for diagnostic, therapeutic and industrial applications. Researchers from the DKFZ and the...
The linear servo MLC presented here provides various advantages over conventionally employed MLCs.
Novel chromatic phase plate designed for STED or RESOLFT fluorescence light microscopy.
The invention discloses an improved version of the chorionallantic membrane, for accurate quantification of metastatic cells in different organs of...
The present invention comprises the use of two serum/plasma markers for stage discrimination and prediction of survival as well as treatment response...
The antibody of this invention is a mouse monoclonal antibody directed against SUMO176-86 recognizing SUMO1 of human, mouse, chicken and X. laevis. It...
The technology provides a peptide array comprising at least 100 polypeptides expressed or expressible from a Chlamydia trachomatis genome or epitopes...
This invention provides a safe Epstein-Barr Virus vaccine, which does not introduce chromosomal instabilities associated with cancer development.
TransferAllianz e. V.
Christiane Bach-Kaienburg
(Geschäftsführerin)
c/o TransMIT GmbH
Kerkrader Straße 3
D-35394 Gießen
0172 6095701
info@transferallianz.de
www.transferallianz.de